Use of radiomic features and support vector machine to distinguish Parkinson's disease cases from normal controls.
暂无分享,去创建一个
Jian Wang | Chuan-Tao Zuo | Yue Wu | Jin-Tai Yu | Jiehui Jiang | Jiaying Lu | C. Zuo | Jian Wang | Jin-Tai Yu | Yue Wu | Li Chen | J. Ge | Fengtao Liu | Wei Lin | Jing-Jie Ge | Jie-Hui Jiang | Li Chen | Jia-Ying Lu | Feng-Tao Liu | Wei Lin | Jin-Tai Yu | Feng-tao Liu
[1] L. Flicker,et al. 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). , 2017, The Cochrane database of systematic reviews.
[2] B. Robottom. Cerebrospinal Fluid Biomarkers for Parkinson Disease Diagnosis and Progression , 2012 .
[3] U. Rajendra Acharya,et al. Parkinson's disease: Cause factors, measurable indicators, and early diagnosis , 2018, Comput. Biol. Medicine.
[4] José Augusto Baranauskas,et al. How Many Trees in a Random Forest? , 2012, MLDM.
[5] A. Rahmim,et al. Investigation of texture quantification parameters for neurological PET image analysis , 2015, 2015 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC).
[6] Irène Buvat,et al. Tumor Texture Analysis in 18F-FDG PET: Relationships Between Texture Parameters, Histogram Indices, Standardized Uptake Values, Metabolic Volumes, and Total Lesion Glycolysis , 2014, The Journal of Nuclear Medicine.
[7] James F. Greenleaf,et al. Use of gray value distribution of run lengths for texture analysis , 1990, Pattern Recognit. Lett..
[8] Yong Liu,et al. Radiomic Features of Hippocampal Subregions in Alzheimer’s Disease and Amnestic Mild Cognitive Impairment , 2018, Frontiers in Aging Neuroscience.
[9] Issam El-Naqa,et al. Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer , 2017, Scientific Reports.
[10] V. Dhawan,et al. Abnormal Metabolic Network Activity in Parkinson'S Disease: Test—Retest Reproducibility , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[11] M. Breteler,et al. Epidemiology of Parkinson's disease , 2006, The Lancet Neurology.
[12] R. Hauser,et al. Nonmotor symptoms of Parkinson’s disease , 2006, Expert review of neurotherapeutics.
[13] Hojjat Adeli,et al. Computer-Aided Diagnosis of Parkinson’s Disease Using Enhanced Probabilistic Neural Network , 2015, Journal of Medical Systems.
[14] P. Khong,et al. MRI texture features may predict differentiation and nodal stage of cervical cancer: a pilot study , 2017, Acta radiologica open.
[15] Antonio P. Strafella,et al. Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts , 2017, Translational Neurodegeneration.
[16] A. Kawaguchi,et al. Dynamic changes in cerebello-thalamo-cortical motor circuitry during progression of Parkinson's disease , 2010, Neuroscience.
[17] P. Lambin,et al. Radiomics: the bridge between medical imaging and personalized medicine , 2017, Nature Reviews Clinical Oncology.
[18] K. Chaudhuri,et al. Non-motor symptoms of Parkinson's disease: diagnosis and management , 2006, The Lancet Neurology.
[19] T. Jiang,et al. Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature , 2018, European Radiology.
[20] Torsten Rohlfing,et al. Combining atlas-based parcellation of regional brain data acquired across scanners at 1.5T and 3.0T field strengths , 2012, NeuroImage.
[21] T. Watabe,et al. Volumetric and texture analysis on FDG PET in evaluating and predicting treatment response and recurrence after chemotherapy in follicular lymphoma , 2019, International Journal of Clinical Oncology.
[22] Belur V. Dasarathy,et al. Image characterizations based on joint gray level-run length distributions , 1991, Pattern Recognit. Lett..
[23] Erwan Scornet,et al. A random forest guided tour , 2015, TEST.
[24] David Eidelberg,et al. Metabolic brain networks in translational neurology: Concepts and applications , 2012, Annals of neurology.
[25] Scott Peltier,et al. Frontiers in Systems Neuroscience Systems Neuroscience Altered Resting State Cortico-striatal Connectivity in Mild to Moderate Stage Parkinson's Disease Materials and Methods Frequency Content Analysis of the Fmri Bold Signal Comparison of Caudate versus Putamen Functional Connectivity in Controls, , 2022 .
[26] Y. Guan,et al. Metabolic brain network in the Chinese patients with Parkinson's disease based on 18F-FDG PET imaging. , 2013, Parkinsonism & related disorders.
[27] Remco J. Renken,et al. Parkinson's disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET imaging , 2014, NeuroImage: Clinical.
[28] D. Oldridge,et al. MRI features predict survival and molecular markers in diffuse lower-grade gliomas , 2017, Neuro-oncology.
[29] Ehsan Adeli,et al. Joint feature-sample selection and robust diagnosis of Parkinson's disease from MRI data , 2016, NeuroImage.
[30] Patrick Granton,et al. Radiomics: extracting more information from medical images using advanced feature analysis. , 2012, European journal of cancer.
[31] D. Eidelberg,et al. Network imaging biomarkers: insights and clinical applications in Parkinson's disease , 2018, The Lancet Neurology.
[32] Martin J. McKeown,et al. Morphological alterations in the caudate, putamen, pallidum, and thalamus in Parkinson's disease , 2015, Front. Neurosci..
[33] Jiehui Jiang,et al. Radiomics: a novel feature extraction method for brain neuron degeneration disease using 18F-FDG PET imaging and its implementation for Alzheimer’s disease and mild cognitive impairment , 2019, Therapeutic advances in neurological disorders.
[34] Benjamin S Aribisala,et al. Assessing the Performance of Atlas-Based Prefrontal Brain Parcellation in an Aging Cohort , 2013, Journal of computer assisted tomography.
[35] S. Lewis,et al. Biomarkers and Parkinson's disease. , 2004, Brain : a journal of neurology.
[36] W. Jost,et al. [Nonmotor symptoms in Parkinson's disease]. , 2017, Der Nervenarzt.
[37] Mary M. Galloway,et al. Texture analysis using gray level run lengths , 1974 .
[38] Wei Lin,et al. Use of Overlapping Group LASSO Sparse Deep Belief Network to Discriminate Parkinson's Disease and Normal Control , 2019, Front. Neurosci..
[39] E. Louis,et al. Emergence of Parkinson's disease in essential tremor: A study of the clinical correlates in 53 patients , 2008, Movement disorders : official journal of the Movement Disorder Society.
[40] B. Choe,et al. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET. , 2004, European journal of radiology.
[41] V. Dhawan,et al. The effect of 18F-FDG-PET image reconstruction algorithms on the expression of characteristic metabolic brain network in Parkinson's disease. , 2017, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.
[42] B. Turgut,et al. Comparison of the volumetric and radiomics findings of 18F-FDG PET/CT images with immunohistochemical prognostic factors in local/locally advanced breast cancer , 2019, Nuclear medicine communications.
[43] Andre Dekker,et al. Radiomics: the process and the challenges. , 2012, Magnetic resonance imaging.
[44] Z. J. Wang,et al. Joint amplitude and connectivity compensatory mechanisms in Parkinson's disease , 2010, Neuroscience.
[45] David J. Brooks,et al. Imaging biomarkers in Parkinson's disease , 2011, Progress in Neurobiology.
[46] Paul Kinahan,et al. Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.
[47] Bernard Fertil,et al. Shape and Texture Indexes Application to Cell nuclei Classification , 2013, Int. J. Pattern Recognit. Artif. Intell..
[48] J. Assmus,et al. Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson's disease. , 2013, Parkinsonism & related disorders.
[49] J R Moeller,et al. Metabolic correlates of pallidal neuronal activity in Parkinson's disease. , 1997, Brain : a journal of neurology.
[50] N. Tzourio-Mazoyer,et al. Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.
[51] D. Brooks. PET studies on the early and differential diagnosis of Parkinson's disease , 1993, Neurology.
[52] P. Lambin,et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.
[53] Hong Yu,et al. Role of hyperactive cerebellum and motor cortex in Parkinson's disease , 2007, NeuroImage.
[54] Robert King,et al. Textural features corresponding to textural properties , 1989, IEEE Trans. Syst. Man Cybern..
[55] W. Gibb,et al. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[56] J. Roerdink,et al. Validation of parkinsonian disease‐related metabolic brain patterns , 2013, Movement disorders : official journal of the Movement Disorder Society.
[57] Elmar Nöth,et al. Characterisation of voice quality of Parkinson's disease using differential phonological posterior features , 2017, Comput. Speech Lang..
[58] Xian Liu,et al. Enhanced Functional Connectivity between Putamen and Supplementary Motor Area in Parkinson’s Disease Patients , 2013, PloS one.
[59] Laura K. Teune,et al. FDG- PET Imaging in Neurodegenerative Brain Diseases , 2013 .
[60] Robert M. Haralick,et al. Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..
[61] Hucheng Zhou,et al. Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease , 2019, Front. Neurosci..
[62] Philippe Lambin,et al. Is there a causal relationship between genetic changes and radiomics-based image features? An in vivo preclinical experiment with doxycycline inducible GADD34 tumor cells. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[63] Sabina Sonia Tangaro,et al. Complex networks reveal early MRI markers of Parkinson's disease , 2018, Medical Image Anal..
[64] P. Payoux,et al. Diagnostic and prognostic value of amyloid PET textural and shape features: comparison with classical semi-quantitative rating in 760 patients from the ADNI-2 database , 2019, Brain Imaging and Behavior.
[65] Xuemei Huang,et al. The Role of the Cerebellum in the Pathophysiology of Parkinson's Disease , 2013, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[66] Marios Politis,et al. Neuroimaging in Parkinson disease: from research setting to clinical practice , 2014, Nature Reviews Neurology.
[67] V. Pérez-García,et al. Intratumoral heterogeneity in 18F-FDG PET/CT by textural analysis in breast cancer as a predictive and prognostic subrogate , 2018, Annals of Nuclear Medicine.
[68] Lin Zhu,et al. PET/SPECT imaging agents for neurodegenerative diseases. , 2014, Chemical Society reviews.
[69] L. Sanders,et al. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease , 2018, Neurobiology of Disease.
[70] N. Michoux,et al. Texture analysis on MR images helps predicting non-response to NAC in breast cancer , 2015, BMC Cancer.
[71] A. Rahmim,et al. Improved prediction of outcome in Parkinson's disease using radiomics analysis of longitudinal DAT SPECT images , 2017, NeuroImage: Clinical.
[72] R. Mailman,et al. Differential involvement of striato- and cerebello-thalamo-cortical pathways in tremor- and akinetic/rigid-predominant Parkinson's disease , 2011, Neuroscience.
[73] Anna Barnes,et al. FDG PET in the differential diagnosis of parkinsonian disorders , 2005, NeuroImage.
[74] David Eidelberg,et al. Assessment of the progression of Parkinson's disease: a metabolic network approach , 2007, The Lancet Neurology.